The informal lunch sessions with renowned AD/PD™ faculty members are now fully booked! In case any spaces become available they will be announced on this page.
- Wednesday, March 18, 2026, from 13:00 – 14:00
- Thursday, March 19, 2026, from 13:00 – 14:00
- Friday, March 20, 2026, from 13:00 – 14:00
- Saturday, March 21, 2026, from 13:10 – 14:10
| Peter St. George-Hyslop, Canada | MOVING FROM COMPUTATIONAL (GWAS, WGS AND MULTIOMICS) TO FUNCTIONAL BIOLOGY | FULLY BOOKED |
| Charlotte Teunissen, Netherlands | BIOMARKER DEVELOPMENT ROADMAP – IT IS ALL ABOUT TEAMWORK | FULLY BOOKED |
| Pamela McLean, USA | BALANCING CAREER, FAMILY, AND LIFE | FULLY BOOKED |
| Maria Grazia Spillantini, UK | SCIENCE, LIFE AND PROTEIN AGGREGATION IN NEURODEGENERATIVE DISEASES | FULLY BOOKED |
| Tiago Outerio, Germany | THE SPECTRUM OF ALPHA-SYNUCLEIN SPECIES | FULLY BOOKED |
| Dimitri Krainc, USA | CAREER OPPORTUNITIES IN ACADEMIA, BIOPHARMA AND VENTURE CAPITAL FIRMS | FULLY BOOKED |
| Frank LaFerla, USA | BUILDING A FOUNDATION FOR EARLY CAREER SUCCESS | FULLY BOOKED |
| Joanna Jankowsky, USA | MODELING DISEASE HETEROGENEITY IN THE LABORATORY | FULLY BOOKED |
| Maria Ankarcrona, Sweden | FUTURE THERAPEUTIC APPROACHES FOR NEURODEGENERATIVE DISEASES- MULTITARGET COMPOUNDS OR A COCKTAIL OF DRUGS? | FULLY BOOKED |
| Michael Schlossmacher, Sweden | FROM HYPOSMIA IN PARKINSON’S TO A TOOL FOR FASTER DIAGNOSIS AND TREATMENT | FULLY BOOKED |
| Kristine Freude, Denmark | SEX DIFFERENCES IN ALZHEIMER’S DISEASE: REALITY, CELL SPECIFICITY, AND MODELING CHALLENGES | FULLY BOOKED |
| Angela Genge, Canada | POTENTIAL DRUG TARGET IN ALS DRUG DEVELOPMENT | FULLY BOOKED |
| Philip Scheltens, The Netherlands | USE OF BIOMARKERS IN THE MEMORY CLINIC | FULLY BOOKED |
| Donna Wilcock, USA | ACHIEVING WORK-LIFE INTEGRATION IN ACADEMIC RESEARCH | FULLY BOOKED |
| Cheryl Wellington, Canada | VASCULAR CONTRIBUTIONS TO COGNITIVE IMPAIRMENT AND DEMENTIA | FULLY BOOKED |
| Bart De Strooper, Belgium | SCIENCE, SERENDIPITY, AND CAREER JOURNEYS: AN OPEN CONVERSATION | FULLY BOOKED |
| Lutz Frolich, Germany | PROSPECTS AND LIMITATIONS OF ANTI-AMYLOID TREATMENT | FULLY BOOKED |
| Agneta Nordberg, Sweden | HOW TO WRITE A WINNING GRANT APPLICATION | FULLY BOOKED |
| Sam Sisodia, USA | HOW GENETICS INFORMS US ABOUT IMMUNE CELLS, THE MICROBIOME AND PATHOPHYSIOLOGY OF AD | FULLY BOOKED |
| Takeshi Iwatsubo, Japan | FROM AD PATHOPHYSIOLOGY TO CLINICAL IMPLEMENTATION OF DISEASE-MODIFYING THERAPIES | FULLY BOOKED |
| Taylor Schmitz, Canada | MOVING TO ANOTHER COUNTRY FOR YOUR GRADUATE AND POSTGRADUATE RESEARCH: MAXIMIZING PROS AND MINIMIZING CONS | FULLY BOOKED |
| Frank Longo, USA | A JOURNEY OF EXECUTING TRANSLATIONAL RESEARCH IN NEURODEGENERATIVE DISEASE – FROM NOVEL CONCEPT TO CLINICAL TRIALS | FULLY BOOKED |
| Henne Holstege, The Netherlands | WHAT CAN WE LEARN FROM CENTENARIANS | FULLY BOOKED |
| Robert Vassar, USA | THERAPEUTIC STRATEGIES TO PREVENT ALZHEIMER’S DISEASE | FULLY BOOKED |
| Rhoda Au, USA | THE MYTH VERSUS THE REALITY OF DIGITAL BIOMARKERS | FULLY BOOKED |
| Lea Grinberg, USA | SPONSORSHIP > MENTORSHIP: BREAKING IN AS A WOMAN SCIENTIST FROM THE GLOBAL SOUTH (AND DODGING THE “TOO-GOOD-TO-BE-TRUE” ALLURES) | FULLY BOOKED |
| Michael Heneka, Luxemburg | NEUROINFLAMMATION | FULLY BOOKED |
| Tim Bartels, UK | TRANSPARENCY AND CONTROVERSY: ADVANCING SCIENCE WITH INTEGRITY | FULLY BOOKED |
| Kenneth Marek, USA | PARKINSON DISEASE PREVENTION | FULLY BOOKED |
| Klaus Gerwert, Germany | STRUCTURE BIOMARKER FOR PARKINSON AND ALZHEIMER RISK | FULLY BOOKED |
| Claudio A. Cuello, Canada | SHOULD WE FOCUS ON TREATING ALZHEIMER’S DISEASE AT PRECLINICAL STAGES? | FULLY BOOKED |
| David Holtzman, USA | MENTORING ADVICE FOR STUDENTS AND POST-DOCS | FULLY BOOKED |
| Stuart A. Lipton, USA | THE INTERFACE OF GENOMICS AND PROTEOMICS IN NEURODEGENERATIVE DISORDERS | FULLY BOOKED |
| Fabrizio Stocchi, Italy | ACTUAL AND FUTURE TREATMENT FOR PD | FULLY BOOKED |
| Daniel Ferreira Padilla, Sweden | LET´S TALK ALL ABOUT DEMENTIA WITH LEWY BODIES | FULLY BOOKED |
| Ornit Chiba-Falek, USA | LEVERAGING OMICS DISCOVERIES TO INCREASE PRECISION IN DRUG DEVELOPMENT FOR NEURODEGENERATIVE DISEASES | FULLY BOOKED |
| Malu Tansey, USA | TARGETING INFLAMMATION AND IMMUNE DYSFUNCTION TO REDUCE RISK AND PROGRESSION OF NEURODEGENERATIVE DISEASES | FULLY BOOKED |
| Bradley Boeve, USA | KEY PEARLS ON MENTORING AND BEING MENTORED | FULLY BOOKED |
| Virginia Lee, USA | TBA | FULLY BOOKED |
You can book your Meet the Professor lunch session when registering for the Conference. If you wish to add Meet the Professor lunch session to your existing registration, please contact us at reg_adpd26@kenes.com